LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Pfizer

Fechado

SetorSaúde

27.73 0.51

Visão Geral

Variação de preço das ações

24h

Atual

Mín

27.3

Máximo

27.93

Indicadores-chave

By Trading Economics

Rendimento

-5.2B

-1.6B

Vendas

903M

18B

P/E

Médio do Setor

19.89

121.746

EPS

0.66

Rendimento de Dividendos

6.32

Margem de lucro

-9.387

Funcionários

81,000

EBITDA

-6.6B

-930M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+6.88% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

6.32%

2.26%

Próximos Ganhos

28 de abr. de 2026

Próxima data de dividendos

6 de mar. de 2026

Próxima data de ex-dividendo

8 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

2.2B

154B

Abertura anterior

27.22

Fecho anterior

27.73

Sentimento de Notícias

By Acuity

42%

58%

126 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Pfizer Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de fev. de 2026, 12:25 UTC

Ganhos

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

20 de jan. de 2026, 10:40 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments -- Update

20 de jan. de 2026, 07:47 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments

10 de fev. de 2026, 21:51 UTC

Ganhos

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 de fev. de 2026, 21:17 UTC

Ganhos

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

3 de fev. de 2026, 21:36 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 de fev. de 2026, 19:56 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 19:46 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More -- Barrons.com

3 de fev. de 2026, 17:35 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 17:30 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, PayPal, Novo Nordisk, Pfizer, Merck, AMD, Gartner, and More -- Barrons.com

3 de fev. de 2026, 13:50 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 13:06 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 12:45 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, PayPal, Teradyne, Tesla, Pfizer, AMD, Merck, and More -- Barrons.com

3 de fev. de 2026, 12:02 UTC

Ganhos

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. -- Barrons.com

3 de fev. de 2026, 11:48 UTC

Ganhos

Pfizer: About 20 Key Pivotal Study Starts Planned for 2026 >PFE

3 de fev. de 2026, 11:48 UTC

Ganhos

Pfizer: Enters 2026 With Clear Strategic Priorities, Growing Late-Stage Pipeline >PFE

3 de fev. de 2026, 11:47 UTC

Ganhos

Pfizer: Current Financial Guidance Doesn't Anticipate Any Stock Buybacks in 2026 >PFE

3 de fev. de 2026, 11:46 UTC

Ganhos

Pfizer Sees 2026 Adjusted R&D Expenses $10.5B-$11.5B >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer Reaffirms 2026 Guidance >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer 4Q Rev $17.56B >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer Sees FY Adj EPS $2.80-Adj EPS $3.00 >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer 4Q Adj EPS 66c >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer 4Q Loss/Shr 29c >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer 4Q Loss $1.65B >PFE

3 de fev. de 2026, 11:45 UTC

Ganhos

Pfizer Sees FY Rev $59.5B-$62.5B >PFE

3 de fev. de 2026, 10:41 UTC

Ganhos

These Stocks Are Today's Movers: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, DaVita, and More -- Barrons.com

20 de jan. de 2026, 07:13 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK PLC: Agreement Simplifies ViiV's Shareholder Structure

20 de jan. de 2026, 07:13 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK PLC to Get Special Div of $0.250B

20 de jan. de 2026, 00:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Shionogi to Acquire Additional Shares in ViiV Healthcare for $2.1B

12 de jan. de 2026, 21:18 UTC

Conversa de Mercado

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

Comparação entre Pares

Variação de preço

Pfizer Previsão

Preço-alvo

By TipRanks

6.88% parte superior

Previsão para 12 meses

Média 28.91 USD  6.88%

Máximo 35.46 USD

Mínimo 25 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Pfizer - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

18 ratings

6

Comprar

12

Manter

0

Vender

Pontuação Técnica

By Trading Central

22.855 / 23.85Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

126 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
help-icon Live chat